Healthcare and Life Science
Deloitte digital consumer trends: over a third of consumers believe GenAI health advice is always accurate
A quarter of GenAI users have used the tool for advice about health or personal problemsHuman interaction in customer service is still the preference for consumers Four in five (81%) UK consumers don’t want AI to replace actors in film and TVA quarter (26%) of GenAI users, have ask...
Beyond capability: The questions I’m hearing
By Lily Lin, CEO of Excellence First Enterprise Consultancy.
What do investors actually want to see from a hardware startup before funding it?
It takes more than a good idea.Investors backing hardware want to see proof of a real problem worth paying to solve, a prototype that demonstrates function, not just looks, a cost structure that still works at true production scale, and a manufacturing plan that's grounded in reality, n...
Problems with cell’s ‘plumbing’ linked to signalling issues in neurodegenerative conditions
New research led by Prof Edward Avezov (UK DRI at Cambridge) reveals how the architecture of the cell’s transport network, the endoplasmic reticulum, can go awry and lead to problems with signalling in brain cells in conditions like Alzheimer’s. The st...
Crossing the Blood-Brain Barrier: Why Natural Transport Mechanisms Are the Smarter Route
Most biologics and even small molecules fail to cross the blood-brain barrier, leaving CNS drug delivery a persistent bottleneck. Isogenica's latest short video looks at why researchers are turning to the brain's own transport systems as a more promising path in. ...
Solving LNP's Liver Problem: Why Targeting Is the Next Frontier in RNA Delivery
Lipid nanoparticles have powered the RNA medicine revolution, but their default tendency to accumulate in the liver limits use beyond hepatic disease. ...
Exonate appoints Olav Hellebø as Chief Executive Officer
Appointment of experienced executive forms part of the Company’s strategy to build momentum across its proprietary platform and therapeutic programs targeting retinal diseasesCompany is preparing a Phase IIb clinical trial of lead candidate EXN407 for diabetic eye diseaseDr Catherine Be...
Precision matters: Guardtech and DryR leading the way for controlled environment provision when things get seriously tight
East Anglian contamination control specialists Guardtech are collaborating with dry room experts DryR to strengthen their overall delivery of advanced cleanroom and dry room facilities across a wide range of high-tech sectors ...
ARU receives £4.8m to boost innovation in the NHS
The NHS Clinical Entrepreneur Programme has already helped launch 691 start-ups.
New Sidney Altman building officially opens at Babraham Research Campus
BioMed Realty UK has today officially opened the Sidney Altman Building at the Babraham Research Campus, unveiling a state-of-the-art facility designed for the next generation of life science innovation. ...